FindTrial
Sign In

Preeclampsia risk prediction registration cohort establishment and clinical observation: regional comprehensive prevention and control project

Preeclampsia risk prediction registration cohort establishment and clinical observation: regional comprehensive prevention and control project

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063216
Enrollment
Unknown
Registered
2022-09-01
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pre-eclampsia

Interventions

Research group:No intervention

Sponsors

Obstetrics & Gynecology Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Women who get preeclampsia risk prediction using maternal factors combined mean arterial pressure, placental growth factor, uterine arterial pulsatility index, according to FIGO:A pragmatic guide for first-trimester screening and prevention guidelines(2019) and consensus of Chinese experts on blood pressure management during pregnancy(2021); 2. Women who get preeclampsia prediction using placental growth factor or soluble fms-like tyrosine kinase-1 and placental growth factor ratio, according to NICE: PlGF-based testing to help diagnose suspected pre-eclampsia guidelings(2016); 3. Either of the above conditions are met and the informed consent is signed.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
pre-eclampsia;—

Secondary

MeasureTime frame
Severe complications of preeclampsia;—

Countries

China

Contacts

Public ContactXiaotian Li

Obstetrics & Gynecology Hospital, Fudan University

xiaotianli555@163.com+86 13818782987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026